Library · Muscle, bone & joint · Joint cartilage protection and regeneration support
Cartalax (Ala-Glu-Asp)
AED peptide, Ala-Glu-Asp tripeptide, Cartalax bioregulator
Synthetic tripeptide (Ala-Glu-Asp) from the early 2000s, studied for cartilage protection and joint health. Preclinical work suggests it may regulate cartilage-degrading enzymes and support proteoglycan/collagen production; remains an unapproved research peptide with limited human data.
Research score 65/100. Reference only, not a dose.
- Joint Support
- Anti-inflammatory
- Recovery Enhancement
- Pain Relief
- US status
- Research Chemical
- Approval
- Research Chemical Only
- Evidence
- Synthetic tripeptide bioregulator targeting cartilage and connective tissue. Used for joint health and osteoarthritis.
- Research score
- 65 / 100
- Indication
- Research Only - No Medical Indication
- Origin
- Russia
- Source category
- Muscles & Joints
- Status group
- Research chemical
Mechanism
Interacts with chondrocyte receptors to boost proteoglycan and type II collagen synthesis, inhibits cartilage-degrading MMPs while raising TIMPs, reduces IL-1β/TNF-α inflammation, and supports chondrocyte survival via PI3K/Akt signaling.
Safety file
Generally reported well tolerated where used, with possible mild allergic reaction or injection-site irritation; long-term human safety data is scarce.
- Injection site reactions
- Joint stiffness
- Temporary joint discomfort
- Mild inflammation